MedTrace Logo

Patient and Provider Assessment of Lipid Management Registry

NCT02341664 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7658

Last updated 2020-03-02

No results posted yet for this study

Summary

The purpose of the Patient and Provider Assessment of Lipid Management Registry (PALM) is to gain a better understanding of physicians' cholesterol medication prescribing practices, patient and physician attitudes and beliefs related to cholesterol management, and current utilization of cholesterol-lowering therapies given the new ACC/AHA guideline recommendations. The PALM Registry hopes to allow for the design of ways to improve cholesterol management and decrease the burden of cardiovascular disease (CVD) in the US.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Tracy Wang, MD · Duke Clinical Research Institute

  • Eric Peterson, MD · Duke Clinical Research Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2016-02-29
Completion
2016-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02341664 on ClinicalTrials.gov